Drug Pricing Lab Report, Hospital outpatient versus physician office cost for physician administered cancer drugs, (Jan 2017).
Conti RM, Bach PB. Cost Consequences of the 340B Drug Discount Program. JAMA: Journal of the American Medical Association. 2013;309(19):1995-1996. doi:10.1001/jama.2013.4156.
See GAO, Rep. No. GAO-15-442, Medicare Part B Drugs: Action Needed to Reduce Financial Incentives to Prescribe 340B Drugs at Participating Hospitals, 20 (June 2015).
H.R. Rep. No. 108-391, at 582-83 (Nov. 2003).